The recently released update to the European League Against Rheumatism (EULAR) guidelines for the management of gout will hopefully lead to substantial improvements in the management and reduction of painful flares, in part by focusing even more strongly on serum uric acid (SUA) levels, according to its authors. At least one gout expert, however, believes the updated guidelines should have focused more closely on the primary care setting, where the majority of gout cases are managed.
These are